Within the ALT positive GBM group the prognosis is better for those individuals with mutations in the tumor protein p53 (TP53) gene, and mutations in the isocitrate dehydrogenase 1 gene [5], [6], [7], [8]. This evidence concerns the gene GPT and glioblastoma.